Antibiotics Global Market Report 2025

Description

Antibiotics, a class of medications, function by either eradicating bacteria or impeding their growth, aiding the body's immune system in eliminating infections. They are employed in the treatment of diverse bacterial infections.

The primary drug classes encompass penicillin, cephalosporin, aminoglycosides, tetracycline, macrolides, fluoroquinolones, sulfonamides, and others. Penicillin, derived from the fungus Penicillium, constitutes a group of antibiotics. The spectrum of activity includes broad-spectrum and narrow-spectrum antibiotics. These antibiotics can be administered through various routes, such as oral, intravenous, and others, and are distributed through hospital pharmacies, retail pharmacies, and online pharmacies. They find applications in treating a range of infections, including skin infections, respiratory infections, urinary tract infections, septicemia, ear infections, gastrointestinal infections, among others.

The antibiotics market research report is one of a series of new reports from The Business Research Company that provides antibiotics market statistics, including the antibiotics industry global market size, regional shares, competitors with an antibiotics market share, detailed antibiotics market segments, market trends, and opportunities, and any further data you may need to thrive in the antibiotics industry. This antibiotics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The antibiotics market size has grown strongly in recent years. It will grow from $84.68 billion in 2024 to $89.31 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to increased incidence of infectious diseases, growing population and urbanization, rising healthcare awareness, access to healthcare services, prevalence of antibiotic-resistant strains

The antibiotics market size is expected to see strong growth in the next few years. It will grow to $110.65 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to global health threats, rising healthcare expenditure, government initiatives and regulations, increased international collaboration. Major trends in the forecast period include development of oral antibiotics, collaboration and partnerships for antibiotic development, regulatory incentives and pathways, antimicrobial stewardship programs in healthcare, global health initiatives for antibiotic access.

The anticipated rise in bacterial infections is poised to be a significant driver for the antibiotics market. Bacterial infections, caused by microscopic single-celled organisms, can be effectively treated and prevented using antibiotics, which impede bacterial growth. A case in point from February 2023, as reported by the World Health Organization, highlighted that 30 countries worldwide were affected by a cholera epidemic in 2022, recording the highest case fatality ratio (CFR) of 1.9% in a decade in 2021. Moreover, data from the Centers for Disease Control and Prevention in April 2023 indicated a 32% increase in syphilis cases in the United States in 2021 compared to 2020. These instances underscore the surge in bacterial infections, thereby propelling the demand for antibiotics within the market.

The escalating healthcare needs of a burgeoning population are expected to drive the growth trajectory of the antibiotics market. The burgeoning population demands increased medical resources, services, and infrastructure to address healthcare challenges effectively. Antibiotics play a pivotal role in addressing these needs by treating bacterial infections, preventing contagious diseases, and safeguarding public health. These medications aid in managing various illnesses, reducing morbidity and mortality rates, supporting medical interventions such as surgeries, chemotherapy, and immunosuppressive therapies. Adequate antibiotic usage is essential to meet the healthcare demands of a growing population and uphold global health standards. Notably, data from the U.S. Census Bureau in September 2022 indicated a 0.4% increase in the United States' resident population, reaching 333,287,557 in 2022, underscoring the imperative role of antibiotics in addressing the healthcare needs of an expanding populace, thereby driving the antibiotics market.

A prominent trend in the antibiotics market involves the rise in new product approvals, with major companies securing regulatory endorsements for their innovative antibiotic formulations. For instance, in January 2023, Alkem Laboratories Ltd., an Indian pharmaceutical firm, introduced Zidavi, a fusion of ceftazidime and avibactam. This medication is specifically designed to address complicated urinary tract infections, intra-abdominal infections, and pneumonia caused by multi-drug resistant (MDR) Gram-negative bacteria. Zidavi stands out as a pivotal advancement in combating antibiotic resistance, serving as one of the few antibiotics effective against MDR Gram-negative bacteria.

Leading companies in the antibiotics market are adopting a strategic partnership approach to improve access to novel antibacterial drugs. Strategic partnerships involve companies leveraging each other's strengths and resources to achieve shared success and benefits. For example, in June 2024, Orchid Pharma Limited, an India-based pharmaceutical company, announced a partnership with Cipla Limited, another India-based pharmaceutical company, to efficiently launch and distribute Cefepime-Enmetazobactam in India. This collaboration combines Orchid Pharma's expertise in innovative drug development with Cipla's vast distribution network to introduce Cefepime-Enmetazobactam, an antibiotic approved for treating complicated urinary tract infections and pneumonia. The goal is to increase access to this essential medication throughout India, while tackling the rising issue of antimicrobial resistance (AMR) and encouraging responsible antibiotic use among healthcare providers.

In July 2022, Innoviva Inc., a US-based healthcare-focused asset management company, completed the acquisition of Entasis Therapeutics Holdings Inc. for an undisclosed amount. This strategic move aims to enhance Innoviva's portfolio by introducing first-in-class antibiotics designed to address multidrug-resistant Gram-negative bacteria. The acquisition not only contributes to diversification but also facilitates the expansion of Innoviva's customer base. Entasis Therapeutics Holdings Inc., a US-based late-stage clinical biopharmaceutical company operating in the antibiotics market, is dedicated to developing, manufacturing, and marketing novel antibacterial products.

Major companies operating in the antibiotics market include Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Bristol Myers Squibb (BMS), AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc (GSK), Eli Lilly and Company, Gilead Sciences Inc., Boehringer Ingelheim, Viatris Inc, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Company, Sun Pharmaceutical Industries Limited, Cipla Ltd., Ferring Pharmaceuticals, Hikma Pharmaceuticals plc, Lupin Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd., Glenmark Pharmaceuticals Limited, Basilea Pharmaceutica Ltd., Paratek Pharmaceuticals Inc., Spero Therapeutics Inc., Nabriva Therapeutics Plc

North America was the largest region in the antibiotics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the antibiotics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The antibiotics market consists of sales of Glycopeptides, Clindamycin, and Quinolones. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Antibiotics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on antibiotics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for antibiotics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The antibiotics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Drug Class: Penicillin, Cephalosporin, Aminoglycosides, Tetracycline, Macrolides, Fluoroquinolones, Sulfonamides, Other Classes
2) By Spectrum Of Activity: Broad-spectrum Antibiotic, Narrow-spectrum Antibiotic
3) By Route Of Administration: Oral, Intravenous, Other Routes
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
5) By Application: Skin Infections, Respiratory Infections, Urinary Tract Infections, Septicemia, Ear Infections, Gastrointestinal Infections, Other Applications
Subsegments:
1) By Penicillin: Natural Penicillins; Aminopenicillins; Penicillinase-resistant Penicillins; Extended-spectrum Penicillins
2) By Cephalosporin: First-generation; Second-generation; Third-generation; Fourth-generation; Fifth-generation
3) By Aminoglycosides: Gentamicin; Tobramycin; Amikacin; Neomycin
4) By Tetracycline: Tetracycline; Doxycycline; Minocycline; Oxytetracycline
5) By Macrolides: Erythromycin; Azithromycin; Clarithromycin
6) By Fluoroquinolones: Ciprofloxacin; Levofloxacin; Moxifloxacin; Ofloxacin
7) By Sulfonamides: Sulfamethoxazole; Sulfadiazine; Sulfasalazine
8) By Other Classes: Glycopeptides; Lipopeptides; Streptogramins; Polymyxins
Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche AG; Merck & Co Inc.; AbbVie Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r24665

1. Executive Summary

2. Antibiotics Market Characteristics

3. Antibiotics Market Trends And Strategies

4. Antibiotics Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Antibiotics Growth Analysis And Strategic Analysis Framework

5.1. Global Antibiotics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Antibiotics Market Growth Rate Analysis
5.4. Global Antibiotics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Antibiotics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Antibiotics Total Addressable Market (TAM)

6. Antibiotics Market Segmentation

6.1. Global Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Penicillin
Cephalosporin
Aminoglycosides
Tetracycline
Macrolides
Fluoroquinolones
Sulfonamides
Other Classes
6.2. Global Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Broad-spectrum Antibiotic
Narrow-spectrum Antibiotic
6.3. Global Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Intravenous
Other Routes
6.4. Global Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
6.5. Global Antibiotics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Skin Infections
Respiratory Infections
Urinary Tract Infections
Septicemia
Ear Infections
Gastrointestinal Infections
Other Applications
6.6. Global Antibiotics Market, Sub-Segmentation Of Penicillin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Natural Penicillins
Aminopenicillins
Penicillinase-resistant Penicillins
Extended-spectrum Penicillins
6.7. Global Antibiotics Market, Sub-Segmentation Of Cephalosporin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
First-generation
Second-generation
Third-generation
Fourth-generation
Fifth-generation
6.8. Global Antibiotics Market, Sub-Segmentation Of Aminoglycosides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gentamicin
Tobramycin
Amikacin
Neomycin
6.9. Global Antibiotics Market, Sub-Segmentation Of Tetracycline, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tetracycline
Doxycycline
Minocycline
Oxytetracycline
6.10. Global Antibiotics Market, Sub-Segmentation Of Macrolides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Erythromycin
Azithromycin
Clarithromycin
6.11. Global Antibiotics Market, Sub-Segmentation Of Fluoroquinolones, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Ciprofloxacin
Levofloxacin
Moxifloxacin
Ofloxacin
6.12. Global Antibiotics Market, Sub-Segmentation Of Sulfonamides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Sulfamethoxazole
Sulfadiazine
Sulfasalazine
6.13. Global Antibiotics Market, Sub-Segmentation Of Other Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Glycopeptides
Lipopeptides
Streptogramins
Polymyxins

7. Antibiotics Market Regional And Country Analysis

7.1. Global Antibiotics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Antibiotics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Antibiotics Market

8.1. Asia-Pacific Antibiotics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Antibiotics Market

9.1. China Antibiotics Market Overview
9.2. China Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Antibiotics Market

10.1. India Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Antibiotics Market

11.1. Japan Antibiotics Market Overview
11.2. Japan Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Antibiotics Market

12.1. Australia Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Antibiotics Market

13.1. Indonesia Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Antibiotics Market

14.1. South Korea Antibiotics Market Overview
14.2. South Korea Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Antibiotics Market

15.1. Western Europe Antibiotics Market Overview
15.2. Western Europe Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Antibiotics Market

16.1. UK Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Antibiotics Market

17.1. Germany Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Antibiotics Market

18.1. France Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Antibiotics Market

19.1. Italy Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Antibiotics Market

20.1. Spain Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Antibiotics Market

21.1. Eastern Europe Antibiotics Market Overview
21.2. Eastern Europe Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Antibiotics Market

22.1. Russia Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Antibiotics Market

23.1. North America Antibiotics Market Overview
23.2. North America Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Antibiotics Market

24.1. USA Antibiotics Market Overview
24.2. USA Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Antibiotics Market

25.1. Canada Antibiotics Market Overview
25.2. Canada Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Antibiotics Market

26.1. South America Antibiotics Market Overview
26.2. South America Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Antibiotics Market

27.1. Brazil Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Antibiotics Market

28.1. Middle East Antibiotics Market Overview
28.2. Middle East Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Antibiotics Market

29.1. Africa Antibiotics Market Overview
29.2. Africa Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Antibiotics Market Competitive Landscape And Company Profiles

30.1. Antibiotics Market Competitive Landscape
30.2. Antibiotics Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Antibiotics Market Other Major And Innovative Companies

31.1. Bayer AG
31.2. Novartis AG
31.3. Sanofi SA
31.4. Bristol Myers Squibb (BMS)
31.5. AstraZeneca plc
31.6. Abbott Laboratories
31.7. GlaxoSmithKline plc (GSK)
31.8. Eli Lilly and Company
31.9. Gilead Sciences Inc.
31.10. Boehringer Ingelheim
31.11. Viatris Inc
31.12. Teva Pharmaceutical Industries Ltd.
31.13. Astellas Pharma Inc.
31.14. Daiichi Sankyo Company
31.15. Sun Pharmaceutical Industries Limited

32. Global Antibiotics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Antibiotics Market

34. Recent Developments In The Antibiotics Market

35. Antibiotics Market High Potential Countries, Segments and Strategies

35.1 Antibiotics Market In 2029 - Countries Offering Most New Opportunities
35.2 Antibiotics Market In 2029 - Segments Offering Most New Opportunities
35.3 Antibiotics Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer